BIOA
BioAge LabsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
BIOA vs peer average
44/100
BIOA vs. peer average (D vs. D)
Grade spread
A 2 · B 1 · D 4 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
LXEO is the first available peer comparator.
Similarly sized biotech candidate; different therapeutic focus limits valuation comparability.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
BIOA
BioAge Labs
LXEO
Lexeo Therapeutics
Grade
D
F
Momentum
2
4
Value
57
41
Sentiment
42
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs LXEO
BIOA / LXEO
Grade Position
Below peers
BIOA vs. peer average (D vs. D)
44/100
Momentum
2
LXEOValue
57
BIOASentiment
42
BIOARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs BIOA
LXEO is the first peer returned for this comparison set.